Actively Recruiting
Diagnosis of Myocardial Ischemia With MCG Using SPECT as a Reference Standard
Led by Qilu Hospital of Shandong University · Updated on 2024-08-21
228
Participants Needed
1
Research Sites
46 weeks
Total Duration
On this page
Sponsors
Q
Qilu Hospital of Shandong University
Lead Sponsor
C
Chongqing Emergency Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a prospective clinical study aiming to investigate the efficacy of Magnetocardiography (MCG) in detecting myocardial ischemia in patients of a suspected non-ST-elevation-acute coronary syndrome (NSTE-ACS) by using Single photon emission computed tomography (SPECT) as the gold standard for determining the presence and severity of myocardial ischemia.
CONDITIONS
Official Title
Diagnosis of Myocardial Ischemia With MCG Using SPECT as a Reference Standard
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Patients with symptoms of myocardial ischemia such as angina pectoris, who have coronary angiography showing less than 70% stenosis at the most severe site or coronary CT angiography showing non-severe stenosis
- Signed informed consent
You will not qualify if you...
- Patients with absolute or relative contraindications to SPECT-loaded myocardial perfusion, including acute myocardial infarction within 48 hours, significant left main coronary artery stenosis, bronchial asthma, and adenosine injection allergy
- Patients with non-ischemic dilated cardiomyopathy, hypertrophic cardiomyopathy, or moderate to severe valvular disease
- Patients with hemodynamic instability (systolic blood pressure less than 90 mmHg or requiring vasoactive drugs), tachyarrhythmia, or first-degree atrioventricular block and above that have not returned to normal
- Patients with severe renal abnormality with eGFR less than 30 ml/min or patients on dialysis
- Patients with malignant tumors with predicted survival less than 1 year
- Pregnant or breastfeeding women
- Patients unable to enter the MCG device, unable to perform MCG examination due to metal implants or other reasons, or deemed unsuitable by investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Qilu Hospital of Shandong University
Jinan, Shandong, China, 250012
Actively Recruiting
Research Team
J
Jiaojiao Pang, Doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here